---
title: "Xtant Medical Holdings, Inc. (XTNT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/XTNT.US.md"
symbol: "XTNT.US"
name: "Xtant Medical Holdings, Inc."
industry: "Health Care Supplies"
---

# Xtant Medical Holdings, Inc. (XTNT.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Location | US Market |
| Website | [xtantmedical.com](https://xtantmedical.com) |

## Company Profile

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into b...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:14.000Z

**Overall: B (0.30)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 7 / 43 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 16.88% |  |
| Net Profit YoY | 109.96% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.64 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 82.46M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 133.08M |  |


**Multi Score**: B

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.64% | C |
| Profit Margin | 1.32% | C |
| Gross Margin | 66.13% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 16.88% | B |
| Net Profit YoY | 109.96% | A |
| Total Assets YoY | 7.52% | B |
| Net Assets YoY | 10.19% | B |

#### Cash Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 7600.40% | A |
| OCF YoY | 16.88% | B |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.30 | A |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 52.61% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Xtant Medical Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.64%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "1.32%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "66.13%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "16.88%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "109.96%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.52%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "10.19%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "A",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "7600.40%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "16.88%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.30",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "52.61%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Essilor (US.ESLOY) | B | B | C | B | B | B |
| 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B |
| 03 | Align (US.ALGN) | B | C | B | B | C | B |
| 04 | Merit Medical (US.MMSI) | B | B | B | C | B | B |
| 05 | UFP Tech (US.UFPT) | B | B | A | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 47.09 | 15/44 | 59.17 | 52.20 | 47.84 |
| PB | 1.64 | 17/44 | 2.13 | 1.82 | 1.64 |
| PS (TTM) | 0.62 | 7/44 | 0.78 | 0.68 | 0.61 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-26T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.58 |
| Highest Target | 1.50 |
| Lowest Target | 1.50 |

## References

- [Company Overview](https://longbridge.com/en/quote/XTNT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/XTNT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/XTNT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.